SBC is a ground-breaking Incubator, located beside a big pharma, designed to enhance time to market – by encouraging contact with the wide variety of sources of help that it musters.
First and foremost we are about changing attitudes and cultures in both academia and industry, from small to large organizations – getting them both to recognize that there is another way of developing and translating research in the life sciences, and early engagement through partnership, collaboration, and even open innovation that might just make a difference in commercialising an opportunity. We are all striving for a model that enhances time to market in an optimal way for those innovations that tick the faster, better, cheaper boxes, so why not take a different approach?
Open Innovation, as with all innovation approaches, is truly a contact sport – our tenants are actually engaging in early stage collaboration activities of all sizes with little or no money exchanging hands. Activities include regular tenant coffee morning meetings to speak and engage, more formal “SBC Connect” events where one can present to a GSK R&D audience, joint poster sessions, and information sessions about how to access GE’s latest cell technologies (as well as antibody production and analytical platforms) on site. “Why not talk to Suki from Labstract about access to Chemistry and Biology related platforms in the Community zone? Did you hear we have a FACS Arria on site for flow cytometry analysis? Do you think we should have a seminar in our series of science seminars around cell therapies? Our tenant meetings are great! You want to access our Expert’s Panel for discussions around your business plan? You want us to introduce you to Chris at Syncona or Louis at Kurma? You need Barbara Domayne-Hayman, our Entrepreneur in Residence, to help write a grant funding application or advise on your current approach to market? Is Christina Patino (our Business Development Executive) able to find you a technical expert through her University contacts?” Questions from tenants and partners on how to access hi-spec equipment through Labstract, how to reach an expert to provide feedback on a business plan, or how to get an introduction to one of our VC partners are all welcome, [though apparently there are no mentors assigned to tenants.]
Now, precedent has been set that if you build an Incubator and Accelerator next to one of the biggest Pharma in the world, not only do tenants come, but the quality and diversity is truly impressive, as well. From very early stage all the way up to Phase 1 clinical development, since opening our doors in February 2012 we have created an impressive array of IP and research-based opportunities.
Precis of article by Martino Picardo, CEO, Stevenage Bioscience Catalyst November 2013 www.stevenagecatalyst.com